GlassScriptPhysician profile
Supriya Krishnan
NPI 1396298428
$1,467.61
in general payments reported to CMS, 2019-2025
17 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.20 · 2020: $62.75 · 2021: $69.29 · 2022: $136 · 2023: $214 · 2024: $573 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $176.69 | 2021-2025 | Precision 1, Dailies Total1, Precision7 |
| Abbvie INC. | $161.40 | 2024-2025 | |
| Johnson & Johnson Vision Care, INC. | $159.32 | 2020-2023 | Acuvue |
| Biotissue Holdings INC. | $144.01 | 2021-2024 | |
| Dompe US, INC. | $142.36 | 2024-2025 | Oxervate |
| Coopervision INC. | $135.93 | 2024-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Bausch & Lomb Americas INC. | $134.97 | 2025 | Xiidra, Miebo |
| Merz North America, INC. | $99.66 | 2024 | |
| Optos, INC. | $81.93 | 2022 | |
| Shire North American Group INC | $40.20 | 2019 | |
| Sight Sciences, INC. | $39.71 | 2022-2023 | Tearcare System |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Glaukos Corporation | $35.09 | 2025 | Photrexa Viscous and Photrexa |
| Novartis Pharmaceuticals Corporation | $29.98 | 2023 | |
| Gilead Sciences, INC. | $19.36 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $15.40 | 2025 | Dextenza |
| Synergeyes, INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriya Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.